Your browser doesn't support javascript.
loading
A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice.
Zhang, Haoxing; Liu, Hailong; Chen, Yali; Yang, Xu; Wang, Panfei; Liu, Tongzheng; Deng, Min; Qin, Bo; Correia, Cristina; Lee, Seungbaek; Kim, Jungjin; Sparks, Melanie; Nair, Asha A; Evans, Debra L; Kalari, Krishna R; Zhang, Pumin; Wang, Liewei; You, Zhongsheng; Kaufmann, Scott H; Lou, Zhenkun; Pei, Huadong.
  • Zhang H; School of Life Sciences, Southwest University, Chongqing 400715, China.
  • Liu H; State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Chen Y; State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Yang X; State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Wang P; State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Liu T; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Deng M; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Qin B; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Correia C; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Lee S; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Kim J; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Sparks M; Department of Cell Biology and Physiology, Washington University, St Louis, Missouri 63130, USA.
  • Nair AA; BSI-Genetics &Bioinformatics, Mayo Clinic, Rochester, Minnesota 55905, USA.
  • Evans DL; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Kalari KR; BSI-Genetics &Bioinformatics, Mayo Clinic, Rochester, Minnesota 55905, USA.
  • Zhang P; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030, USA.
  • Wang L; Molecular Pharmacology and Experimental therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA.
  • You Z; Department of Cell Biology and Physiology, Washington University, St Louis, Missouri 63130, USA.
  • Kaufmann SH; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
  • Lou Z; State Key Laboratory of Proteomics, Beijing Proteome Research Center, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Pei H; Division of Oncology Research, Mayo Clinic, Rochester, MN 55905, USA.
Nat Commun ; 7: 10201, 2016 Jan 05.
Article en En | MEDLINE | ID: mdl-26727879
ABSTRACT
BRCA1 is an important mediator of the DNA damage response, which promotes homologous recombination (HR) and antagonizes 53BP1-dependent non-homologous end joining in S/G2 phase. But how this is achieved remains unclear. Here, we report that the E3 ubiquitin ligase UHRF1 (Ubiquitin-like, with PHD and RING finger domains 1) directly participates in the interplay between BRCA1 and 53BP1. Mechanistically, UHRF1 is recruited to DNA double-strand breaks (DSBs) by BRCA1 in S phase, which requires the BRCT domain of BRCA1 and phosphorylated Ser674 of UHRF1. Subsequently, UHRF1 mediates K63-linked polyubiquitination of RIF1, and results in its dissociation from 53BP1 and DSBs thereby facilitating HR initiation. Thus, UHRF1 is a key regulator of DSB repair choice, which is separate from its role in heterochromatin formation and epigenetic regulator.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína BRCA1 / Proteínas Potenciadoras de Unión a CCAAT / Reparación del ADN / Roturas del ADN de Doble Cadena Límite: Humans Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína BRCA1 / Proteínas Potenciadoras de Unión a CCAAT / Reparación del ADN / Roturas del ADN de Doble Cadena Límite: Humans Idioma: En Año: 2016 Tipo del documento: Article